Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (75) Arrow Down
Filter Results: (75) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (122)
    • People  (1)
    • News  (31)
    • Research  (75)
  • Faculty Publications  (9)

Show Results For

  • All HBS Web  (122)
    • People  (1)
    • News  (31)
    • Research  (75)
  • Faculty Publications  (9)
← Page 2 of 75 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 25 Sep 2018
  • First Look

New Research and Ideas, September 25, 2018

operations. Product failures are, therefore, likely to impact firms’ subsequent innovation activities. Using 13 years of Food and Drug Administration data, we examine the effects of firm and competitor medical device recalls on subsequent... View Details
Keywords: Dina Gerdeman
  • 23 Oct 2018
  • First Look

New Research and Ideas, October 23, 2018

media to engage others and build campaigns for change in the company. This case follows her career at the company and describes the challenges she faced as a change agent, working to promote gender equality within the company and a new View Details
Keywords: Dina Gerdeman
  • 08 Jun 2010
  • First Look

First Look: June 8

case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074 This case presents the Myelin... View Details
Keywords: Martha Lagace
  • 12 Feb 2019
  • First Look

New Research and Ideas, February 12, 2019

Devices: Challenges and Opportunities for U.S. Regulators and Innovators By: Gordon, William J., and Ariel Dora Stern Abstract— Software has become an increasingly important component of medical device technology. Through legislation like the 21st Century Cures Act as... View Details
Keywords: Dina Gerdeman
  • 18 Apr 2018
  • First Look

First Look at New Research and Ideas, April 18, 2018

organization among enterprises specializing in overseas ventures, they did not become the dominant form of large enterprises within British economy itself. Business groups organized under the holding company such as Calico Printers'... View Details
Keywords: Sean Silverthorne
  • 21 Aug 2018
  • First Look

New Research and Ideas, August 21, 2018

growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby largely... View Details
Keywords: Dina Gerdeman
  • 27 Feb 2019
  • Research & Ideas

The Hidden Cost of a Product Recall

Evidence from Medical Device Firms, released in January. Bigger recalls, bigger reactions Using 13 years of US Food and Drug Administration data and a novel set of competitor classification algorithms, the team created a detailed history... View Details
Keywords: by Danielle Kost; Manufacturing; Consumer Products; Auto; Medical Devices & Supplies
  • 26 Jan 2015
  • Research & Ideas

National Health Costs Could Decrease if Managers Reduce Work Stress

Mortality and Health Costs in the United States, written with Stanford business professors Jeffrey Pfeffer and Stefanos A. Zenios. Goh specializes in developing complex mathematical models that can aid decision making, especially in the... View Details
Keywords: by Michael Blanding; Health
  • 12 Dec 2005
  • Research & Ideas

Using the Law to Strategic Advantage

create value and manage risk. Q: Most managers don't have law degrees, so who do they turn to get the legal background they will need to work with legal staff on the issues you identify? Will they need special training? A: I like to think... View Details
Keywords: by Sean Silverthorne; Legal Services
  • 13 Jul 2020
  • Research & Ideas

Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

gives away a drug called Mectizan for river blindness. That's one pill per person per year. And we found it's really hard to get that the last mile to the people who really need it. Okay? So I would say there are two big issues with... View Details
Keywords: by Staff; Pharmaceutical
  • 21 Oct 2015
  • Research & Ideas

How to Predict if a New Business Idea is Any Good

industry like drug development, it’s not like you can just switch from one disease to another disease,” she says. While R&D-intensive ventures can shift the application of their underlying technology, Shu continues, the fact they are... View Details
Keywords: by Michael Blanding; Accommodations; Financial Services
  • 25 Aug 2003
  • Research & Ideas

Why IT Does Matter

Radio-frequency identification devices for grocery stores, smart cards, and automated ordering systems for hospital physicians are all examples of new process targets that technologies will soon address. In the more distant future we will see the improved creation of... View Details
Keywords: by F. Warren McFarlan & Richard L. Nolan
  • 05 Jul 2006
  • Research & Ideas

The Accidental Innovator

direct special attention to it." Similarly, Daguerre, who invented photography, made his breakthrough when he put an exposed plate into a cabinet in which a thermometer had earlier shattered; mercury vapors from the broken... View Details
Keywords: by Sarah Jane Gilbert
  • 19 Sep 2016
  • Research & Ideas

Why Isn't Business Research More Relevant to Business Practitioners?

disciplines, where academic research is leading to the development of a second skin that could improve drug delivery or alerting farmers and scientists on how to reduce nitrous oxide emissions from agricultural farming. Harvard Business... View Details
Keywords: by Carmen Nobel; Education
  • 29 May 2001
  • Research & Ideas

Genomics: Can We Start Making Money Now?

Now that scientists have mapped the human gene, can drug makers map a road to unlimited riches? For John Lechleiter, Executive Vice President of Eli Lilly and Company's Pharmaceutical Products and Corporate Development, there remain more... View Details
Keywords: by Sean Silverthorne
  • 10 Sep 2008
  • Research & Ideas

Long-Tail Economics? Give Me Blockbusters!

you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details
Keywords: by John Quelch; Entertainment & Recreation; Pharmaceutical
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • 07 Apr 2003
  • Research & Ideas

Three Steps for Crisis Prevention

counterpart at Honeywell, Michael Bonsignore, were rushing to close the deal (United Technologies was also eager to acquire Honeywell), they "reportedly never held initial consultations with their Brussels lawyers who specialize in... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
  • 12 Jul 2020
  • Research & Ideas

Solving COVID'S Mental Health Crisis

for everyone and also highlighted the important link between research, discovery, and cure." The GPP is a statewide prevention program aimed at reducing the use of dangerous drugs among teens and young adults through awareness campaigns,... View Details
Keywords: by Howard Stevenson and Shirley Spence; Health
  • 08 Apr 2009
  • Research & Ideas

Clayton Christensen on Disrupting Health Care

screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced into the general population, like what happened with Vioxx.... View Details
Keywords: by Deborah Blagg; Health
  • ←
  • 1
  • 2
  • 3
  • 4
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.